Pericardial NT-Pro-BNP and GDF-15 as Biomarkers of Atrial Fibrillation and Atrial Matrix Remodeling in Aortic Stenosis.
Mariana Fragão-MarquesIsaac BarrosoRui FarinhaIsabel M MirandaDiana MartinsJennifer MancioJoão Rocha NevesJoão Tiago GuimarãesAdelino Leite-MoreiraInês Falcão-PiresPublished in: Diagnostics (Basel, Switzerland) (2021)
GDF-15 and NT-pro-BNP in the pericardial fluid are biomarkers of atrial fibrillation in aortic stenosis and correlate with atrial matrix remodeling. AKI is predicted by both serum and pericardial fluid GDF-15.
Keyphrases
- aortic stenosis
- atrial fibrillation
- transcatheter aortic valve replacement
- left atrial
- catheter ablation
- ejection fraction
- left ventricular
- aortic valve replacement
- aortic valve
- transcatheter aortic valve implantation
- oral anticoagulants
- left atrial appendage
- direct oral anticoagulants
- coronary artery disease
- heart failure
- anti inflammatory
- acute kidney injury
- percutaneous coronary intervention
- mitral valve
- venous thromboembolism